Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2001
11/01/2001WO2001080822A2 Effervescent granules and methods for their preparation
11/01/2001WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001WO2001034582A3 Sordaricin derivatives having antifungal activity
11/01/2001WO2001032866A3 Hybrid adaptor receptors
11/01/2001WO2001030329A3 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction
11/01/2001WO2001029084A3 Novel human proteins and polynucleotides encoding the same
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001WO2001025187A3 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
11/01/2001WO2001013910A3 Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001WO1999013816A3 Liposomal camptothecin formulations
11/01/2001US20010037019 A mixture of salt of 7-amino-3-methyl-cephalosporanic acid (7-ADCA) and a salt of 7-amino-3-vinyl-cephalosporanic acid is subjected to crystallization, isolating crystal salt, converted into 7-ADCA, then performing chromatography
11/01/2001US20010036963 Octenidine dihydrochloride, C1 to C8-alkyl alcohol, alkylpolyglycoside non-ionic and quaternary betaine cationic surfactants, water, alpha-hydroxycarboxylic acid
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036941 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders
11/01/2001US20010036940 Chemical intermediates
11/01/2001US20010036923 Complex
11/01/2001US20010036920 Method for treating papillomavirus infections
11/01/2001US20010036914 Use of polyamino acid derivatives as preserving agents, compositions comprising them and preserving process using them
11/01/2001US20010036655 Vaccine
11/01/2001US20010036482 Antimicrobial compositions for mastitis control
11/01/2001US20010036462 Enhancing immunology response
11/01/2001US20010036461 Human immunodeficiency virus vaccine
11/01/2001US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001US20010036456 Administering Protein C
11/01/2001US20010036452 Interleukin-1 muteins useful as vaccine adjuvants
11/01/2001CA2407455A1 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407448A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407083A1 Apo-ai/aii peptide derivatives
11/01/2001CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001CA2406998A1 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
11/01/2001CA2406949A1 Use of particulate vectors in immunomodulation
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406532A1 Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus compri sing alkyl and aryl alanine p2 moieties
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2406004A1 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof
11/01/2001CA2405961A1 Bispecific molecules and uses thereof
11/01/2001CA2404998A1 Cytotoxic agents
11/01/2001CA2399741A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/2001
10/31/2001EP1149917A2 Hepatitis B virus vectors for gene therapy
10/31/2001EP1149913A1 Cytokine immunoconjugates
10/31/2001EP1149910A1 Pharmaceutical composition for treating papillomavirus tumours and infection
10/31/2001EP1149901A1 Pestivirus mutants and vaccines containing the same
10/31/2001EP1149834A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
10/31/2001EP1149586A1 Bidirectional modulation of immunity
10/31/2001EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection
10/31/2001EP1149171A1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof
10/31/2001EP1149167A2 Viral vaccine
10/31/2001EP1149166A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
10/31/2001EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
10/31/2001EP1149159A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149094A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
10/31/2001EP1149089A2 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148885A1 Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
10/31/2001EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
10/31/2001EP1044201A4 3-substituted adenines via2-thioxanthines
10/31/2001EP0980248B1 Improvements in or relating to long-acting antimicrobials
10/31/2001EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0819124B1 Azole compounds with antimycotic activity for human and veterinary use
10/31/2001EP0754180B1 Anti-helicobacter ester and carbamate derivatives of azolones
10/31/2001EP0747381B1 Carbapenem derivative
10/31/2001EP0699077B1 Hiv immunogenic complexes
10/31/2001EP0624160B1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
10/31/2001EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
10/31/2001EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications
10/31/2001DE10020813A1 Verwendung von N2-substituierten Benz[f]indazol-4,9-chinonen als Antiparasitika Use of N2-substituted benz [f] indazole-4,9-quinones as antiparasitic
10/31/2001DE10020812A1 Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika Use of Naphthindazol-4,9-quinones as antiparasitic
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10019136A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001DE10019135A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001CN1320128A Beta-L-2-deoxy-nucleosides for the treatment of hepatitis B
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/31/2001CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320041A Treatment of hepatitis B infection with thymosin alpha 1 and lamivudine
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001CN1320035A Antibiotic compositions for treatment of the eye, ear and nose
10/31/2001CN1319587A Heterocyclonitrogen heteroethane derivant with antiviral activity
10/31/2001CN1319427A Nursing liquid of menstrual period
10/31/2001CN1319416A Liquid medicine for treating influenza virus and preparation process thereof
10/31/2001CN1319395A Refapentine or rifampin liposome perfusate, injection and preparation process thereof
10/31/2001CN1073853C Medicinal pill for clearing away heat and treating pulmonary tuberculosis
10/31/2001CN1073845C Liniment film for onychomycosis and its preparation technology
10/30/2001US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents
10/30/2001US6310190 USPA1 and USPA2 antigens of Moraxella catarrhalis
1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 1798